BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27035648)

  • 1. Transcription factor‑microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.
    Liu HY; Huang YL; Liu JQ; Huang Q
    Mol Med Rep; 2016 May; 13(5):3920-8. PubMed ID: 27035648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.
    Hou Y; Wang Y; Xu S; Qi G; Wu X
    Mol Med Rep; 2019 Jul; 20(1):281-291. PubMed ID: 31115532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
    Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
    Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
    Wei L; Xin C; Wang W; Hao C
    Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.
    Lan CW; Chen MJ; Tai KY; Yu DC; Yang YC; Jan PS; Yang YS; Chen HF; Ho HN
    Sci Rep; 2015 Oct; 5():14994. PubMed ID: 26459919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peripheral blood transcriptome identifies dysregulation of inflammatory response genes in polycystic ovary syndrome.
    Su NJ; Ma J; Feng DF; Zhou S; Li ZT; Zhou WP; Deng H; Liang JY; Yang XH; Zhang YM; Liu FH; Zhang L
    Gynecol Endocrinol; 2018 Jul; 34(7):584-588. PubMed ID: 29262729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
    Bi X; Zhai Z; Wang S
    Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.
    Huang X; Pan J; Wu B; Teng X
    Reprod Biol Endocrinol; 2018 Aug; 16(1):73. PubMed ID: 30075721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis.
    Yang Y; Xing Y; Liang C; Hu L; Xu F; Mei Q
    Int J Mol Med; 2016 Jun; 37(6):1449-56. PubMed ID: 27121343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
    Liu L; He D; Wang Y; Sheng M
    Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray.
    Sun Z; Wang Y; Wei T; Liu L
    BMC Med Genomics; 2022 Dec; 15(1):267. PubMed ID: 36544152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
    Shen H; Liang Z; Zheng S; Li X
    Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.
    Zhang Y; Zhao T; Hu L; Xue J
    Reprod Sci; 2023 Oct; 30(10):3055-3070. PubMed ID: 37171773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subpathway-based method of drug reposition for polycystic ovary syndrome.
    Liu HY; Liu JQ; Mai ZX; Zeng YT
    Reprod Sci; 2015 Apr; 22(4):423-30. PubMed ID: 25015903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.
    Du J; Zhang L
    Oncol Rep; 2015 Aug; 34(2):585-94. PubMed ID: 26035298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome.
    Liu S; Zhang X; Shi C; Lin J; Chen G; Wu B; Wu L; Shi H; Yuan Y; Zhou W; Sun Z; Dong X; Wang J
    J Transl Med; 2015 Jul; 13():238. PubMed ID: 26198660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
    Liu Y; Yu J; Li J; Li W; Ma H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis.
    Yang D; Li N; Ma A; Dai F; Zheng Y; Hu X; Wang Y; Xian S; Zhang L; Yuan M; Liu S; Deng Z; Yang Y; Cheng Y
    Reprod Sci; 2021 May; 28(5):1353-1361. PubMed ID: 33067753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A putative molecular network associated with colon cancer metastasis constructed from microarray data.
    Chu S; Wang H; Yu M
    World J Surg Oncol; 2017 Jun; 15(1):115. PubMed ID: 28629469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.